ZNF696
gene geneOn this page
Also known as FLJ14129
Summary
ZNF696 (zinc finger protein 696, HGNC:25872) is a protein-coding gene on chromosome 8q24.3, encoding Zinc finger protein 696 (Q9H7X3). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 79943 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 81 total
- MANE Select transcript:
NM_030895
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25872 |
| Approved symbol | ZNF696 |
| Name | zinc finger protein 696 |
| Location | 8q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ14129 |
| Ensembl gene | ENSG00000185730 |
| Ensembl biotype | protein_coding |
| Entrez | 79943 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 15 protein_coding
ENST00000330143, ENST00000518432, ENST00000518575, ENST00000520333, ENST00000521537, ENST00000523891, ENST00000909971, ENST00000909972, ENST00000909973, ENST00000909974, ENST00000924642, ENST00000971662, ENST00000971663, ENST00000971664, ENST00000971665
RefSeq mRNA: 1 — MANE Select: NM_030895
NM_030895
CCDS: CCDS6399
Canonical transcript exons
ENST00000330143 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001321271 | 143295740 | 143299952 |
| ENSE00001368892 | 143291417 | 143291767 |
| ENSE00003636662 | 143292972 | 143293065 |
Expression profiles
Bgee: expression breadth ubiquitous, 221 present calls, max score 88.87.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.9352 / max 48.3036, expressed in 1464 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 91399 | 3.9084 | 1462 |
| 91397 | 0.0225 | 4 |
| 91398 | 0.0043 | 1 |
Top tissues by expression
267 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tendon of biceps brachii | UBERON:0008188 | 88.87 | gold quality |
| endothelial cell | CL:0000115 | 86.52 | gold quality |
| buccal mucosa cell | CL:0002336 | 84.68 | gold quality |
| cortical plate | UBERON:0005343 | 81.64 | gold quality |
| medial globus pallidus | UBERON:0002477 | 80.39 | gold quality |
| vena cava | UBERON:0004087 | 80.26 | silver quality |
| globus pallidus | UBERON:0001875 | 79.08 | gold quality |
| apex of heart | UBERON:0002098 | 78.85 | gold quality |
| ventricular zone | UBERON:0003053 | 78.54 | gold quality |
| right frontal lobe | UBERON:0002810 | 78.35 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.14 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 77.85 | gold quality |
| ganglionic eminence | UBERON:0004023 | 77.75 | gold quality |
| cingulate cortex | UBERON:0003027 | 77.74 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 76.80 | gold quality |
| sural nerve | UBERON:0015488 | 76.80 | gold quality |
| cerebellar vermis | UBERON:0004720 | 76.50 | silver quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 76.38 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 76.22 | gold quality |
| prefrontal cortex | UBERON:0000451 | 76.11 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 75.90 | gold quality |
| nucleus accumbens | UBERON:0001882 | 75.86 | gold quality |
| neocortex | UBERON:0001950 | 75.84 | gold quality |
| cerebellar cortex | UBERON:0002129 | 75.83 | gold quality |
| right lobe of liver | UBERON:0001114 | 75.71 | gold quality |
| amygdala | UBERON:0001876 | 75.70 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 75.70 | gold quality |
| granulocyte | CL:0000094 | 75.68 | gold quality |
| metanephros cortex | UBERON:0010533 | 75.55 | gold quality |
| body of tongue | UBERON:0011876 | 75.55 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.44 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2524.1 | ZNF696 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605530
miRNA regulators (miRDB)
61 targeting ZNF696, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-3934-3P | 99.76 | 65.51 | 1351 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-132-3P | 99.73 | 70.56 | 1424 |
| HSA-MIR-212-3P | 99.73 | 70.65 | 1424 |
| HSA-MIR-4802-3P | 99.72 | 70.13 | 1273 |
| HSA-MIR-5580-3P | 99.70 | 69.41 | 2052 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-5004-3P | 99.54 | 68.27 | 1371 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 696 — Q9H7X3 (reviewed: Q9H7X3)
All UniProt accessions (6): E5RFI7, E5RG39, E5RH76, E5RH99, E5RJV3, Q9H7X3
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_112157* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (13 total): zinc finger region 9, chain 1, region of interest 1, compositionally biased region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H7X3-F1 | 76.25 | 0.58 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 38 (showing top):
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN, NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, chr8q24, BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING, PRC2_SUZ12_UP.V1_DN, TGFB_UP.V1_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, DACH1_TARGET_GENES, EBNA1BP2_TARGET_GENES, HOXB4_TARGET_GENES, SFMBT1_TARGET_GENES, SNIP1_TARGET_GENES, UBN1_TARGET_GENES, ZNF22_TARGET_GENES
GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
548 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF696 | KRABD3 | A5PL33 | 535 |
| ZNF696 | CLEC2A | Q6UVW9 | 520 |
| ZNF696 | LYG2 | Q86SG7 | 516 |
| ZNF696 | TMPRSS5 | Q9H3S3 | 429 |
| ZNF696 | XKR9 | Q5GH70 | 420 |
| ZNF696 | KCNJ12 | Q14500 | 412 |
| ZNF696 | FAM171A2 | A8MVW0 | 406 |
| ZNF696 | ADAMTSL2 | Q86TH1 | 382 |
| ZNF696 | ABHD12B | Q7Z5M8 | 379 |
| ZNF696 | ZFYVE28 | Q9HCC9 | 368 |
| ZNF696 | KLHDC10 | Q6PID8 | 367 |
| ZNF696 | ADTRP | Q96IZ2 | 336 |
| ZNF696 | PPP1R16A | Q96I34 | 329 |
| ZNF696 | CES4A | Q5XG92 | 325 |
| ZNF696 | PYCR3 | Q53H96 | 321 |
IntAct
156 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MDFI | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.670 |
| VWC2 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.670 |
| GPR156 | PLD2 | psi-mi:“MI:0914”(association) | 0.640 |
| VWCE | HSPA5 | psi-mi:“MI:0914”(association) | 0.640 |
| KRTAP1-3 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TRIM41 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZNF526 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF696 | PDE4DIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA6L9 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DVL3 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTUS2 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCNDBP1 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-5 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF696 | MID2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CALCOCO2 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP4-12 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-9 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP9-2 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEP70 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-7 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX1A | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-8 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-1 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP12-3 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDC14B | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP17-1 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TENM4 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | ZNF696 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (82): ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS), ZNF696 (Affinity Capture-MS)
ESM2 similar proteins: A3KN32, A6NM28, A8K8V0, E9PYI1, O75467, O95201, P10072, P10075, P10078, P10754, P28698, P30373, P52736, Q0VCC5, Q14929, Q16587, Q17QR7, Q29RZ4, Q3KNW1, Q3TDE8, Q3US17, Q58DK7, Q5RJR4, Q5T619, Q5TEC3, Q5U4E2, Q62396, Q68H95, Q6AW86, Q6PGE4, Q6ZMY9, Q7Z398, Q7Z7K2, Q8BI73, Q8BIF9, Q8BIQ3, Q8BKK5, Q8JZL0, Q8N393, Q8R0T2
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 96 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Molecules associated with elastic fibres | 5 | 26.6× | 2e-04 |
| Keratinization | 13 | 12.5× | 6e-09 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
81 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 74 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
547 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:143292967:A:G | acceptor_gain | 0.9800 |
| 8:143295739:GCT:G | acceptor_gain | 0.9800 |
| 8:143292966:A:AG | acceptor_gain | 0.9700 |
| 8:143293061:TGCAG:T | donor_loss | 0.9700 |
| 8:143293063:CAGG:C | donor_loss | 0.9700 |
| 8:143293064:AGGTG:A | donor_loss | 0.9700 |
| 8:143293065:GG:G | donor_loss | 0.9700 |
| 8:143293067:T:A | donor_loss | 0.9700 |
| 8:143294110:GC:G | donor_gain | 0.9700 |
| 8:143295738:A:AG | acceptor_gain | 0.9700 |
| 8:143295739:G:GG | acceptor_gain | 0.9700 |
| 8:143292969:CAG:C | acceptor_loss | 0.9600 |
| 8:143292970:A:C | acceptor_loss | 0.9600 |
| 8:143292971:G:T | acceptor_loss | 0.9600 |
| 8:143292962:A:AG | acceptor_gain | 0.9500 |
| 8:143292971:GA:G | acceptor_gain | 0.9500 |
| 8:143291742:G:GT | donor_gain | 0.9400 |
| 8:143292963:C:G | acceptor_gain | 0.9400 |
| 8:143292968:GCA:G | acceptor_gain | 0.9400 |
| 8:143292970:A:AG | acceptor_gain | 0.9400 |
| 8:143292971:G:GG | acceptor_gain | 0.9400 |
| 8:143292971:GAA:G | acceptor_gain | 0.9400 |
| 8:143293028:TGCTA:T | donor_gain | 0.9400 |
| 8:143293068:G:GT | donor_loss | 0.9400 |
| 8:143295734:TTTCA:T | acceptor_loss | 0.9400 |
| 8:143295737:CA:C | acceptor_loss | 0.9400 |
| 8:143295739:G:GC | acceptor_loss | 0.9400 |
| 8:143295739:GC:G | acceptor_gain | 0.9300 |
| 8:143295739:GCTGT:G | acceptor_gain | 0.9300 |
| 8:143292793:G:GT | donor_gain | 0.9200 |
AlphaMissense
2441 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:143296159:T:C | F162L | 0.999 |
| 8:143296161:C:A | F162L | 0.999 |
| 8:143296161:C:G | F162L | 0.999 |
| 8:143296243:T:C | F190L | 0.999 |
| 8:143296245:C:A | F190L | 0.999 |
| 8:143296245:C:G | F190L | 0.999 |
| 8:143296579:T:C | F302L | 0.999 |
| 8:143296581:C:A | F302L | 0.999 |
| 8:143296581:C:G | F302L | 0.999 |
| 8:143296495:T:C | F274L | 0.998 |
| 8:143296497:C:A | F274L | 0.998 |
| 8:143296497:C:G | F274L | 0.998 |
| 8:143296747:T:C | F358L | 0.998 |
| 8:143296749:C:A | F358L | 0.998 |
| 8:143296749:C:G | F358L | 0.998 |
| 8:143296270:C:A | H199N | 0.997 |
| 8:143296327:T:C | F218L | 0.997 |
| 8:143296329:C:A | F218L | 0.997 |
| 8:143296329:C:G | F218L | 0.997 |
| 8:143296663:T:C | F330L | 0.997 |
| 8:143296665:C:A | F330L | 0.997 |
| 8:143296665:C:G | F330L | 0.997 |
| 8:143296159:T:A | F162I | 0.996 |
| 8:143296243:T:A | F190I | 0.996 |
| 8:143296270:C:G | H199D | 0.996 |
| 8:143296272:C:A | H199Q | 0.996 |
| 8:143296272:C:G | H199Q | 0.996 |
| 8:143296579:T:A | F302I | 0.996 |
| 8:143296690:C:A | H339N | 0.996 |
| 8:143296524:C:A | H283Q | 0.995 |
dbSNP variants (sampled 300 via entrez): RS1000917159 (8:143298970 G>A), RS1000984964 (8:143291530 G>A,C), RS1001119856 (8:143293678 C>A,T), RS1001291641 (8:143290912 C>A,G,T), RS1001299250 (8:143293440 G>A), RS1001892198 (8:143294675 G>A,T), RS1001923807 (8:143299934 G>A), RS1001925570 (8:143300177 G>A), RS1002013787 (8:143289502 G>A,C), RS1002330844 (8:143296573 C>A,G,T), RS1002418278 (8:143291314 C>T), RS1002578785 (8:143296202 G>A,C), RS1002615508 (8:143295637 A>G), RS1002685137 (8:143296808 C>T), RS1002759219 (8:143297399 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002392_524 | Mean corpuscular volume | 2.000000e-12 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects methylation, increases expression, increases methylation | 2 |
| triphenyl phosphate | affects expression | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | affects cotreatment, decreases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Arsenic | decreases methylation, increases expression | 1 |
| Diazinon | increases methylation | 1 |
| Estradiol | increases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Smoke | decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.